DRREDDY Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > drreddy

Technical Analysis

Technical Strength: 2.9 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 24.4. According to RSI analysis, drreddy is oversold. 7.0 DRREDDY RSI Chart
MACD (?) MACD: -80.5 and Signal Line: -69.5. According to MACD analysis, drreddy is technically weak. 2.0 DRREDDY MACD Chart
Simple Moving Average (?) According to simple moving average analysis, drreddy is in a strong downtrend. Major resistance levels are 2772.662, 2899.523, 3100.408. 0.0 DRREDDY Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, drreddy is in a strong downtrend. Major resistance levels are 2756.504, 2872.106, 3056.804. 0.0 DRREDDY Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.127. According to bollinger bands, drreddy is technically weak. 3.0 DRREDDY Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 2792.7276 and 2866.1. Support level is 2555.2. 2.5 DRREDDY Fibonacci Retracement Chart
Average True Range (?) ATR: 53.9 NA DRREDDY Average True Range Chart
Average Directional Index (?) ADX is 41.7 which means DRREDDY is in a trend. NA DRREDDY Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
March 24, 2017
Open Price 2630.8
High Price 2645.0
Low Price 2616.35
Close Price 2628.35
Absolute Change -2.85
Percentage Change -0.108%
Weekly Change -3.94%
Monthly Change -9.47%
Yearly Change -16.7%
52-week high 3689.85
52-week low 2555.2
Corporate Actions
ExDate Purpose
July 18, 2016 AGM/DIV-RS 20 PER SHARE
July 10, 2015 AGM/DIV RS 20/- PER SHARE
July 11, 2014 AGM/DIV-RS 18 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.488
Confidence in Beta1.15%
Market Capital Rs. 44834.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 79.15
TTM Price-to-Earnings (P/E) Ratio 33.2
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 24 March 2017: Deliverable Quantity:2.16e+05 NA DRREDDY Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 24 March 2017: Daily Volatility:0.2923 NA DRREDDY Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 24 March 2017: PCR_OI:0.366 PCR:0.743 NA DRREDDY PCR Chart
Premium (?) 24 March 2017 Premium: -0.4 Futures OI:3435800.0 NA DRREDDY Premium Chart
Option_MAX_OI (?) 24 March 2017: Price:2628.35 Put with maximum OI:2600.0 Call with maximum OI:3000.0 NA DRREDDY Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
March 30, 2017 2627.95 3435800.0 4449.0 5064.0 2628.35
April 27, 2017 2637.45 575000.0 1273.0 1718.0 2628.35
May 25, 2017 2663.0 6000.0 1.0 1.0 2628.35

Announcements

March 14, 2017 Dr.Allotment of ESOP/ESPS. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 8973 Equity Shares under ESOP
March 09, 2017 Dr.Press Release. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 08, 2017, titled "Intimation regarding completion of audit of our formulation manufacturing facility at Duvvada, Visakhapatnam, by the US FDA.".
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 10, 2017 February 04, 2017 intResultster alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016.
October 05, 2016 October 25, 2016 intResultster alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2016.
See all Board Meetings

DRREDDY is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 2586 Rs. 2601 Rs. 2615 Rs. 2630 Rs. 2643 Rs. 2659 Rs. 2672